ceric oxide has been researched along with Respiratory Distress Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilodeaux, J; Knudsen, L; Kolanthai, E; Lehmann, T; Liechty, KW; Niemiec, S; Nozik, E; Seal, S; Smith, BJ; Vaughn, AE; Wallbank, AM; Zgheib, C | 1 |
| Allawzi, A; Azeltine, M; Dewberry, LC; Elajaili, H; Hilton, SA; Hu, J; Liechty, KW; Louiselle, AE; Mattson, C; Niemiec, SM; Nozik-Grayck, E; Sakthivel, TS; Sea, S; Singh, S; Smith, B; Wallbank, A; Xu, J; Zgheib, C | 1 |
2 other study(ies) available for ceric oxide and Respiratory Distress Syndrome
| Article | Year |
|---|---|
CNP-miR146a improves outcomes in a two-hit acute- and ventilator-induced lung injury model.
Topics: Acute Lung Injury; Animals; Humans; Lung; Mice; Respiratory Distress Syndrome; Ventilator-Induced Lung Injury | 2023 |
Cerium oxide nanoparticle delivery of microRNA-146a for local treatment of acute lung injury.
Topics: Animals; Bleomycin; Cerium; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Delivery Systems; Male; Mice; MicroRNAs; Respiratory Distress Syndrome; SARS-CoV-2 | 2021 |